News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,889 Results
Type
Article (39238)
Company Profile (282)
Press Release (650369)
Section
Business (203948)
Career Advice (1999)
Deals (35386)
Drug Delivery (89)
Drug Development (80891)
Employer Resources (168)
FDA (16112)
Job Trends (14815)
News (344736)
Policy (32455)
Tag
Academia (2530)
Alliances (49260)
Alzheimer's disease (1290)
Approvals (16078)
Artificial intelligence (160)
Bankruptcy (354)
Best Places to Work (11603)
Biotechnology (199)
Breast cancer (204)
Cancer (1525)
Cardiovascular disease (121)
Career advice (1665)
CAR-T (106)
Cell therapy (312)
Clinical research (64938)
Collaboration (566)
Compensation (308)
COVID-19 (2549)
C-suite (133)
Data (1470)
Diabetes (189)
Diagnostics (6199)
Earnings (85032)
Employer resources (146)
Events (110356)
Executive appointments (483)
FDA (16886)
Funding (514)
Gene therapy (214)
GLP-1 (621)
Government (4338)
Healthcare (18738)
Infectious disease (2646)
Inflammatory bowel disease (114)
Interviews (309)
IPO (16393)
Job creations (3625)
Job search strategy (1418)
Layoffs (424)
Legal (7870)
Lung cancer (225)
Manufacturing (214)
Medical device (13233)
Medtech (13238)
Mergers & acquisitions (19258)
Metabolic disorders (493)
Neuroscience (1651)
NextGen: Class of 2025 (6506)
Non-profit (4471)
Northern California (1868)
Obesity (281)
Opinion (186)
Patents (133)
People (56643)
Phase I (20211)
Phase II (28601)
Phase III (21305)
Pipeline (614)
Postmarket research (2561)
Preclinical (8554)
Radiopharmaceuticals (239)
Rare diseases (286)
Real estate (5893)
Regulatory (21785)
Research institute (2312)
Resumes & cover letters (349)
Southern California (1614)
Startups (3565)
United States (16630)
Vaccines (578)
Weight loss (194)
Date
Today (132)
Last 7 days (405)
Last 30 days (1955)
Last 365 days (34866)
2025 (1724)
2024 (35252)
2023 (40078)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35020)
2017 (32110)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29265)
2010 (27330)
Location
Africa (713)
Arizona (203)
Asia (37399)
Australia (6107)
California (4243)
Canada (1556)
China (362)
Colorado (190)
Connecticut (205)
Europe (80068)
Florida (605)
Georgia (147)
Illinois (413)
Indiana (242)
Maryland (685)
Massachusetts (3279)
Michigan (183)
Minnesota (317)
New Jersey (1183)
New York (1203)
North Carolina (786)
Northern California (1868)
Ohio (154)
Pennsylvania (1000)
South America (1093)
Southern California (1614)
Texas (618)
Utah (120)
Washington State (428)
689,889 Results for "icad inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference
iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, announced today the Company will present at the MedInvest MedTech, AI & Digital Healthcare Conference on June 11-12, 2024 in San Francisco, CA.
June 4, 2024
·
3 min read
Business
iCAD Reports Financial Results for First Quarter Ended March 31, 2024
iCAD, Inc. today reported its financial and operating results for the three months ended March 31, 2024.
May 15, 2024
·
17 min read
Business
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
iCAD, Inc. (NASDAQ: ICAD) today announced results for its fiscal fourth quarter and full year ended December 31, 2023, as compared to the corresponding period of the last fiscal year.
March 12, 2024
·
21 min read
Press Releases
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference
November 6, 2024
·
3 min read
Press Releases
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024
November 6, 2024
·
3 min read
Pharm Country
iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare
iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced that key artificial intelligence (AI) powered solutions from iCAD’s ProFound Breast Health Suite are the first applications to be offered in GE HealthCare’s new MyBreastAI Suite* offering.
November 28, 2023
·
4 min read
Business
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
iCAD, Inc. (NASDAQ: ICAD) announced today the Company will release financial results for the fourth quarter and full year 2023 financials after the market close, and host a conference call at 4:30 PM Eastern Time on Tuesday, March 12, 2024.
February 27, 2024
·
3 min read
Press Releases
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024
November 26, 2024
·
10 min read
Press Releases
iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024
September 11, 2024
·
4 min read
Business
iCAD Expands Executive Sales Leadership Team as Business Grows
iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, announced the expansion of its sales leadership with the addition of Peter Graham, as Senior Vice President, North American Sales and a role change for Bill Keyes to Senior Vice President, Global Sales Operations, both effective immediately.
December 18, 2023
·
2 min read
1 of 68,989
Next
